{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig4puttnbcjutbj2eauvqtalgsa7xvi6w3h7uyc5tlachqq2ozmge",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfvffzn65342"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih4p5k7v4kfejjfobrnnj6wuqs666t5nyp3imimrld6iakafhtymy"
    },
    "mimeType": "image/jpeg",
    "size": 764987
  },
  "path": "/news/2026-02-blood-bladder-cancer-patients-safely.html",
  "publishedAt": "2026-02-27T21:50:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence within the bladder, according to new data presented today by Fox Chase Cancer Center researchers.",
  "title": "Blood test predicts which bladder cancer patients may safely skip surgery"
}